PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals
Visit https://www.peervoice.com/GJD860 to view the entire programme with slides. After completing “Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals”, participants will be able to: Propose the most appropriate sequence of life-prolonging agents, including radiopharmaceuticals, for patients with metastatic castration-resistant prostate cancer (mCRPC); Evaluate clinical trial data guiding the use of radiopharmaceuticals within the overall treatment paradigm for mCRPC; and Design holistic therapeutic regimens to maximise patient quality of life through optimisation of bone health and clear communication of treatment expectations.